EP4338805
Eikósapentaenósýru-etýl-ester til notkunar við að draga úr áhættunni á hjartadrepi sem er ekki banvænt í einstaklingi sem er í statín-meðferð
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
28.6.2013EP published:
4.6.2025EP application number:
24152359.6
EP translation filed:
9.9.2025Grant published:
15.10.2025EPO information:
European Patent Register
Max expiry date:
27.6.2033Expiry date:
27.6.2026Next due date:
30.6.2026
Title in English:
EICOSAPENTAENOIC ACID ETHYL ESTER FOR USE IN REDUCING THE RISK OF NON-FATAL MYOCARDIAL INFARCTION IN A SUBJECT ON STATIN THERAPYLanguage of the patent:
English
Timeline
Today
28.6.2013EP application
4.6.2025EP Publication
9.9.2025Translation submitted
15.10.2025Registration published
27.6.2026Expires
Owner
Name:
Amarin Pharmaceuticals Ireland LimitedAddress:
88 Harcourt Street, Dublin 2, D02 DK18, IE
Inventor
Name:
SONI, PareshAddress:
Mystic, 06355, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201261666447 PDate:
29.6.2012Country:
US
Classification
Categories:
A61K 31/232, A61K 31/397, A61K 45/06, A61P 9/10, A61P 9/00, A61P 3/04, A61P 3/06, A61P 9/04, A61P 9/06, A61P 43/00
Annual fees
Number
Paid
Expires
Payer
Number: 13
Paid: 8.9.2025
Expires: 27.6.2026
Payer: Árnason Faktor ehf.